title: Successful treatment of perianal giant condyloma acuminatum in an immunocompromised host with systemic interleukin 2 and topical cidofovir.
authors.affiliation: Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Vinod E
authors.initials: VE
authors.lastname: Nambudiri
authors.forename: Kudakwashe
authors.initials: K
authors.lastname: Mutyambizi
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Walls
authors.forename: David C
authors.initials: DC
authors.lastname: Fisher
authors.forename: Ronald
authors.initials: R
authors.lastname: Bleday
authors.forename: Arturo P
authors.initials: AP
authors.lastname: Saavedra
mesh_terms: D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000473:pathology / Q000628:therapy*; D062688:Buschke-Lowenstein Tumor / Q000473:pathology / Q000628:therapy*; D000077404:Cidofovir; D003131:Combined Modality Therapy; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007376:Interleukin-2; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir